- Home
- PRM vs TERN Comparison
PRM vs TERN Comparison
Compare PRM & TERN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | PRM | TERN |
|---|---|---|
| Founded | 2018 | 2017 |
| Country | United States | United States |
| Employees | 371 | N/A |
| Industry | Newspapers/Magazines | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 4.9B | 4.8B |
| IPO Year | N/A | 2021 |
Fundamental Metrics
Financial Performance| Metric | PRM | TERN |
|---|---|---|
| Price | $29.96 | $52.97 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 2 | 12 |
| Target Price | $27.50 | ★ $45.22 |
| AVG Volume (30 Days) | 1.3M | ★ 6.2M |
| Earning Date | 05-06-2026 | 05-14-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 8.04 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $30.45 | N/A |
| Revenue Next Year | $8.44 | N/A |
| P/E Ratio | $51.56 | ★ N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $12.77 | $3.55 |
| 52 Week High | $34.89 | $53.19 |
Technical Indicators
Market Signals| Indicator | PRM | TERN |
|---|---|---|
| Relative Strength Index (RSI) | 46.03 | 74.51 |
| Support Level | $26.98 | $52.42 |
| Resistance Level | $31.92 | $53.19 |
| Average True Range (ATR) | 1.42 | 0.07 |
| MACD | -0.47 | -0.31 |
| Stochastic Oscillator | 11.07 | 97.30 |
Price Performance
Historical ComparisonAbout PRM Perimeter Solutions SA
Perimeter Solutions Inc is a solutions provider for the Fire Safety and Specialty Products industries. The company's products and operations are managed and reported in two operating segments. Its Fire Safety segment provides fire retardants and firefighting foams, as well as specialized equipment and services typically offered in conjunction with the company's retardant and foam products. The Specialty Products segment develops, produces, and markets phosphorus pentasulfide (P2S5)-based products used in lubricant additives, as well as in pesticide, mining chemical, and battery applications.
About TERN Terns Pharmaceuticals Inc.
Terns Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. The company is developing a portfolio of small-molecule single-agent and combination therapy candidates for the treatment of non-alcoholic steatohepatitis, NASH, and other chronic liver diseases. Its product candidates include TERN-701, TERN-601, TERN-501 and TERN-800.